Assessing the need for revaccination is warranted and is an approach currently used for hepatitis B vaccination in patients receiving dialysis [55]; however, such monitoring is not performed for COVID-19 due to poorly defined correlates of protection against the omicron variant [34, 56]. This evidence concerns the gene PPIB and hepatitis A virus infection.